/PRNewswire/ PostEra, a biotechnology company specializing in machine learning for preclinical drug discovery, today announced a multi-year collaboration.
/PRNewswire/ PostEra, a biotechnology company specializing in machine learning for preclinical drug discovery, today announced a multi-year collaboration.
By Riley Griffin & Josh Wingrove In its quest to build up its stockpile of Covid-19 drugs, the US government has held talks with Japanese drugmaker Shionogi & Co. about buying its experimental antiviral pill, people familiar with the matter said. Finding the money to pay for it could be…
Shionogi's treatment is in late-stage clinical trials and hasn’t yet been authorized, but in earlier studies, it reduced viral loads in patients within the first few days of use.